Alluvi tirzepatide is emerged as a promising therapeutic agent for the management of metabolic diseases. This exploratory evaluation investigated the efficacy and tolerability of tirzepatide 40mg in animal models of insulin resistance. The experiments demonstrated that tirzepatide 40mg markedly enhanced glycemic control and lowered insulin sensitiv… Read More